HutchMED (China) LIMITED Comprehensive Income
HutchMED (China) LIMITED (HMDCF) reported Comprehensive Income of $458.85 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-05.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-03-05
- HutchMED (China) LIMITED comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2019-12-31 was -$27.84M.
- HutchMED (China) LIMITED comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2019-09-30 was -$36.27M.
- HutchMED (China) LIMITED comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2019-06-30 was -$30.03M.
- HutchMED (China) LIMITED comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2019-03-31 was -$15.50M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2025-12-31 | $458.85M 20-F · filed 2026-03-05 | |||
| 2025-06-30 | $455.94M 6-K · filed 2025-08-07 | |||
| 2024-12-31 | $34.31M 20-F · filed 2026-03-05 | |||
| 2024-06-30 | $24.43M 6-K · filed 2025-08-07 | |||
| 2023-12-31 | $94.54M 20-F · filed 2026-03-05 | |||
| 2023-06-30 | $162.65M 6-K · filed 2024-07-31 | |||
| 2022-12-31 | -$368.31M 20-F · filed 2025-03-19 | |||
| 2022-06-30 | -$166.55M 6-K · filed 2023-07-31 | |||
| 2021-12-31 | -$192.11M 20-F · filed 2024-02-28 | |||
| 2021-06-30 | -$101.54M 6-K · filed 2022-08-01 | |||
| 2020-12-31 | -$117.40M 20-F · filed 2023-02-28 | |||
| 2020-06-30 | -$51.38M 6-K · filed 2021-07-28 | |||
| 2019-12-31 | -$27.84M derived: 20-F 12 month − 6-K 9 month · filed 2022-03-03 | -$64.10M derived: sum of 2 quarters · filed 2022-03-03 | -$94.13M derived: sum of 3 quarters · filed 2022-03-03 | -$109.63M 20-F · filed 2022-03-03 |
| 2019-09-30 | -$36.27M derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | -$66.30M derived: sum of 2 quarters · filed 2020-07-30 | -$81.79M 6-K · filed 2020-01-21 | -$97.95M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-06-30 | -$30.03M derived: 6-K 6 month − 6-K 3 month · filed 2020-07-30 | -$45.53M 6-K · filed 2020-07-30 | -$61.69M derived: sum of 3 quarters · filed 2021-03-04 | -$96.45M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-03-31 | -$15.50M 6-K · filed 2019-06-06 | -$31.66M derived: sum of 2 quarters · filed 2021-03-04 | -$66.43M derived: sum of 3 quarters · filed 2021-03-04 | -$91.12M derived: sum of 4 quarters · filed 2021-03-04 |
| 2018-12-31 | -$16.16M derived: 20-F 12 month − 6-K 9 month · filed 2021-03-04 | -$50.93M derived: sum of 2 quarters · filed 2021-03-04 | -$75.62M derived: sum of 3 quarters · filed 2021-03-04 | -$80.48M 20-F · filed 2021-03-04 |
| 2018-09-30 | -$34.77M derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | -$59.46M derived: sum of 2 quarters · filed 2020-01-21 | -$64.32M 6-K · filed 2020-01-21 | |
| 2018-06-30 | -$24.69M derived: 6-K 6 month − 6-K 3 month · filed 2019-07-30 | -$29.55M 6-K · filed 2019-07-30 | ||
| 2018-03-31 | -$4.86M 6-K · filed 2019-06-06 | |||
| 2017-12-31 | -$17.03M 20-F · filed 2020-03-03 | |||
| 2017-06-30 | $4.63M 6-K · filed 2018-07-27 | |||
| 2016-12-31 | $2.41M 20-F · filed 2019-03-11 | |||
| 2016-06-30 | -$2.15M 6-K · filed 2017-07-31 | |||
| 2015-12-31 | $3.14M 20-F · filed 2018-03-12 | |||
| 2014-12-31 | -$9.74M 20-F · filed 2017-03-13 |